ArticleGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2026
5-year outcomes of ahmed glaucoma valve implantation after failed trabeculotomy in primary congenital glaucoma.
Article in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate the long-term efficacy, surgical survival, and complication profile of Ahmed Glaucoma Valve (AGV) implantation following failed trabeculotomy in eyes with primary congenital glaucoma (PCG). STUDY
designRetrospective observational cohort study.
methodsTwenty-seven eyes of 27 children diagnosed with PCG who underwent AGV implantation after failed trabeculotomy at a tertiary referral center were included. Baseline demographics, intraocular pressure (IOP) measurements, postoperative interventions, and complications were recorded. Surgical success was defined as IOP between 6 and 21 mmHg with (qualified) or without (complete) medications and no major complications or additional glaucoma surgery. Failure was defined as uncontrolled IOP, repeated cyclophotocoagulation (CPC), visually significant complications, or loss of light perception.
resultsThe mean age at trabeculotomy and AGV implantation was 4.8 ± 2.1 and 25.9 ± 7.4 months, respectively. Mean preoperative IOP was 37.0 ± 3.0 mmHg and decreased to 20.5 ± 2.0 mmHg at final follow-up (mean duration 66.5 ± 12.3 months). Only 1 eye (3.7%) achieved complete success and 5 eyes (18.5%) achieved qualified success, whereas 22 eyes (81.5%) met criteria for surgical failure. Kaplan-Meier analysis demonstrated a marked reduction in both complete and qualified survival probabilities after postoperative year 2, stabilizing at 3.7% and 18.5%, respectively, by year 5. All failed eyes required repeated CPC (mean 2.3 ± 0.6 sessions/year), and 6 eyes (22.2%) underwent needling procedures (mean 1.4 ± 0.3/year).
conclusionsAGV implantation following failed trabeculotomy provides meaningful initial IOP reduction in refractory PCG; however, long-term durability is limited, with success rates declining sharply beyond the second postoperative year.
Indexed as
Identifiers
42611055What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.